Los Angeles Times | May 24, 2022
“This is a very good vaccine, but the FDA has slow-walked it every step of the way,” said Lawrence Gostin, an expert in public health law expert at Georgetown University.
Los Angeles Times | May 24, 2022
“This is a very good vaccine, but the FDA has slow-walked it every step of the way,” said Lawrence Gostin, an expert in public health law expert at Georgetown University.